---
schema_version: "secwatch.filing_event.v1"
accession: "0001607062-21-000309"
form_type: "8-K/A"
ticker: "RGBP"
cik: "0001589150"
company_name: "Regen BioPharma Inc"
filed_at: "2021-08-31T23:59:59+00:00"
generated_at: "2026-06-29T06:45:39.551607+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# Regen Biopharma corrects convertible debt date, becomes current on SEC filings, plans to settle notes

## Summary
- Corrects earlier statement: no convertible debt issued since July 2019, not July 2020.
- Company is no longer delinquent in SEC reporting as of August 27, 2021 10-Q filing.
- Intends to negotiate settlement of remaining convertible notes to reduce or eliminate dilution, no assurance given.

## SEC filing metadata
- accession: 0001607062-21-000309
- form_type: 8-K/A
- ticker: RGBP
- cik: 0001589150
- company_name: Regen BioPharma Inc
- filed_at: 2021-08-31T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1589150/000160706221000309/0001607062-21-000309-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1589150/000160706221000309/rgbp083121form8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001607062-21-000309
- JSON: https://secwatch.observer/filing/0001607062-21-000309.json
- Plain text: https://secwatch.observer/filing/0001607062-21-000309.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.